Ketamine Completed Phase 1 Trials for Major Depressive Disorder (MDD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02165449Biomarkers of Fast Acting Therapies in Major Depression
NCT00548964Continuation Ketamine in Major Depression